Archived News
2004
Ascenta raises Series B Financing of $30 Million, with Bank of America, Sofinnova, Domain, Enterprise and US-Venture Partners
Return to top of page
Appointment of J. Mel Sorensen, M.D., as President and Chief Executive Officer of Ascenta Therapeutics
Return to top of page
Appointment of Jon Holmlund, M.D., as Chief Medical Officer and Vice-President of Development to Ascenta Therapeutics
Return to top of page
Appointment of Dajun Yang, M.D., Ph.D., as Vice-President of Research of Ascenta Therapeutics
Return to top of page
